Category: AI News


  • Innovation vs oversight in drug regulation

    [ad_1] The US Food and Drugs Administration (FDA) has stated that it wants to accelerate the deployment of AI across its centres. FDA Commissioner Martin A. Makary has announced an aggressive timeline to scale use of AI by 30 June 2025 and is betting big on the technology to change drug approval processes for the…

  • Saudi Arabia moves to build its AI future with HUMAIN and NVIDIA

    [ad_1] Saudi Arabia’s new state subsidiary, HUMAIN, is collaborating with NVIDIA to build AI infrastructure, nurture talent, and launch large-scale digital systems. The effort includes plans to set up AI “factories” powered by up to 500 megawatts of energy. The sites will be filled with NVIDIA GPUs, including the Grace Blackwell GB300 supercomputers connected via…

  • US slams brakes on AI Diffusion Rule, hardens chip export curbs

    [ad_1] The Department of Commerce (DOC) has slammed the brakes on the sweeping “AI Diffusion Rule,” yanking it just a day before it was due to bite. Meanwhile, officials have laid down the gauntlet with stricter measures to control semiconductor exports. The AI Diffusion Rule, a piece of regulation cooked up under the Biden administration,…

  • Open-source AI video tool for all

    [ad_1] Alibaba has unveiled Wan2.1-VACE, an open-source AI model designed to shake up how we create and edit videos. VACE isn’t appearing out of thin air; it’s part of Alibaba’s broader Wan2.1 family of video AI models. And they’re making a rather bold claim for it, stating it’s the “first open-source model in the industry…

  • AI in business intelligence: Caveat emptor

    [ad_1] One of the ways in which organisations are using the latest AI algorithms to help them grow and thrive is the adoption of privately-held AI models in aligning their business strategies. The differentiation between private and public AI is important in this context – most organisations are rightly wary of allowing public AIs access…

  • Why Microsoft is cutting roles despite strong earnings

    [ad_1] Microsoft is cutting about 7,000 jobs, or 3% of its workforce. The move isn’t about poor performance or falling revenue. It’s a clear shift in strategy—fewer layers, more engineers, and more investment in artificial intelligence. The layoffs affect staff across divisions and global offices. But the bulk of those let go are in middle…

  • Congress pushes GPS tracking for every exported semiconductor

    [ad_1] America’s quest to protect its semiconductor technology from China has taken increasingly dramatic turns over the past few years—from export bans to global restrictions—but the latest proposal from Congress ventures into unprecedented territory.  Lawmakers are now pushing for mandatory GPS-style tracking embedded in every AI chip exported from the United States, essentially turning advanced…

  • Can the US really enforce a global AI chip ban?

    [ad_1] When Huawei shocked the global tech industry with its Mate 60 Pro smartphone featuring an advanced 7-nanometer chip despite sweeping US technology restrictions, it demonstrated that innovation finds a way even under the heaviest sanctions. The US response was swift and predictable: tighter export controls and expanded restrictions. Now, with reports suggesting Huawei’s Ascend…

  • Will the AI boom fuel a global energy crisis?

    [ad_1] AI’s thirst for energy is ballooning into a monster of a challenge. And it’s not just about the electricity bills. The environmental fallout is serious, stretching to guzzling precious water resources, creating mountains of electronic waste, and, yes, adding to those greenhouse gas emissions we’re all trying to cut. As AI models get ever…

  • The Download: the first personalized gene-editing drug, and Montana’s Right to Try experiment

    [ad_1] Doctors say they constructed a bespoke gene-editing treatment in less than seven months and used it to treat a baby with a deadly metabolic condition. The rapid-fire attempt to rewrite the child’s DNA marks the first time gene editing has been tailored to treat a single individual. The baby who was treated, Kyle “KJ”…